Table 3.
Frequency of microorganisms by type of samples in COVID-19 standard ward and critical care patients.
| Respiratory samples | N = 28 (32.6%) |
| Candida albicans | 12 (37.5%) |
| Pseudomonas aeruginosa | 8 (21.8%) |
| Staphylococcus aureus | 5 (15.6%) |
| Klebsiella pneumoniae | 2 (6.3%) |
| Influenza A/ B | 4 (12.5%) |
| Aspergillus fumigatus | 2 (6.3%) |
| Hafnia alvei | 2 (6.3%) |
| Stenotrophomonas maltophilia | 1 (3.1%) |
| Candida tropicalis | 1 (3.1%) |
| Candida norvegensis | 1 (3.1%) |
| Blood cultures | N = 43 (50%) |
| Staphylococcus epidermidis | 16 (35.8%) |
| Others coagulasa negative Staphylococci | 13 (22.6%) |
| Staphylococcus aureus | 5 (9.4%) |
| Enterococcus faecalis | 4 (9.4%) |
| Candida albicans | 4 (9.4%) |
| Enterococcus faecium | 3 (5.7%) |
| Hafnia alvei | 2 (3.8%) |
| Streptococcus pneumoniae | 2 (3.8%) |
| Pseudomonas aeruginosa | 1 (1.9%) |
| Morganella morganii | 1 (1.9%) |
| Klebsiella pneumonia | 1 (1.9%) |
| Serratia marcescens | 1 1.9%) |
| Urinary Antigen | N = 15 (17.4%) |
| Streptococcus pneumonia | 15 (100%) |
There are samples with more than one microorganism.